# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stifel analyst Daniel Arias maintains Bruker (NASDAQ:BRKR) with a Hold and lowers the price target from $81 to $77.
B of A Securities analyst Derik De Bruin maintains Bruker (NASDAQ:BRKR) with a Buy and lowers the price target from $95 to $90.
NanoString, now a Bruker business, will promptly seek an end to the injunction impacting sales of CosMx SMI products in Germany...
15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targ...
Fiscal Year 2024 Financial Outlook Bruker's FY 2024 updated guidance now includes the expected benefits of the Chemspeed a...